Company filings profile · CIK 0001837607
AEON Biopharma, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for AEON Biopharma, Inc. (AEON): 19 filings in the last 90 days vs 19 in the prior 90 (filing-velocity steady · 1×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Aug 5, 2026. Source-linked, daily-refreshed.
Material 8-K events — AEON Biopharma, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Aug 3, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Jul 23, 2026 | Other Events | ↗ |
| Jul 15, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 17, 2026 | Item 5.07 | ↗ |
| May 14, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 14, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 3, 2026 | Delisting / Listing-Rule Failure; Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 9, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
Watch AEON Biopharma, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Aug 3, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Jul 23, 2026 | 8-K | Other Events | ↗ |
| Jul 21, 2026 | SCHEDULE 13G | ↗ | |
| Jul 15, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jul 15, 2026 | 424B4 | 424B4 | ↗ |
| Jul 13, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jul 13, 2026 | S-1MEF | S-1MEF | ↗ |
| Jul 9, 2026 | S-1/A | S-1/A | ↗ |
| Jul 8, 2026 | S-1 | S-1 | ↗ |
| Jun 22, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jun 22, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jun 22, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jun 22, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jun 22, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jun 17, 2026 | 8-K | Item 5.07 | ↗ |
| May 29, 2026 | DRS | ↗ | |
| May 14, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| May 14, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 29, 2026 | ARS | ARS | ↗ |
| Apr 29, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 29, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 3, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Apr 3, 2026 | 3 | OWNERSHIP DOCUMENT | ↗ |
| Apr 3, 2026 | 8-K | Delisting / Listing-Rule Failure; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | S-8 | S-8 | ↗ |
| Mar 30, 2026 | 10-K | 10-K | ↗ |
| Mar 30, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 11, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Mar 9, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Mar 5, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Mar 5, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Feb 19, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Feb 18, 2026 | 424B3 | 424B3 | ↗ |
| Feb 17, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Feb 12, 2026 | CORRESP | ↗ | |
| Feb 12, 2026 | UPLOAD | ↗ | |
| Feb 9, 2026 | S-3 | S-3 | ↗ |
| Jan 29, 2026 | 3 | ↗ | |
| Jan 29, 2026 | SCHEDULE 13D | ↗ |